186 related articles for article (PubMed ID: 21160049)
1. Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.
Miles JJ; Thammanichanond D; Moneer S; Nivarthi UK; Kjer-Nielsen L; Tracy SL; Aitken CK; Brennan RM; Zeng W; Marquart L; Jackson D; Burrows SR; Bowden DS; Torresi J; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
J Immunol; 2011 Jan; 186(2):901-12. PubMed ID: 21160049
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
3. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
Gras S; Saulquin X; Reiser JB; Debeaupuis E; Echasserieau K; Kissenpfennig A; Legoux F; Chouquet A; Le Gorrec M; Machillot P; Neveu B; Thielens N; Malissen B; Bonneville M; Housset D
J Immunol; 2009 Jul; 183(1):430-7. PubMed ID: 19542454
[TBL] [Abstract][Full Text] [Related]
4. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
[TBL] [Abstract][Full Text] [Related]
5. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
[TBL] [Abstract][Full Text] [Related]
7. TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity.
Pasetto A; Frelin L; Aleman S; Holmström F; Brass A; Ahlén G; Brenndörfer ED; Lohmann V; Bartenschlager R; Sällberg M; Bertoletti A; Chen M
J Immunol; 2012 Nov; 189(9):4510-9. PubMed ID: 23024278
[TBL] [Abstract][Full Text] [Related]
8. An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant.
Nivarthi UK; Gras S; Kjer-Nielsen L; Berry R; Lucet IS; Miles JJ; Tracy SL; Purcell AW; Bowden DS; Hellard M; Rossjohn J; McCluskey J; Bharadwaj M
J Immunol; 2014 Dec; 193(11):5402-13. PubMed ID: 25355921
[TBL] [Abstract][Full Text] [Related]
9. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex.
Koning D; Costa AI; Hoof I; Miles JJ; Nanlohy NM; Ladell K; Matthews KK; Venturi V; Schellens IM; Borghans JA; Kesmir C; Price DA; van Baarle D
J Immunol; 2013 Feb; 190(3):931-9. PubMed ID: 23267020
[TBL] [Abstract][Full Text] [Related]
10. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
[TBL] [Abstract][Full Text] [Related]
11. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1997 Jan; 158(1):485-91. PubMed ID: 8977226
[TBL] [Abstract][Full Text] [Related]
12. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.
Ziegler S; Ruhl M; Tenckhoff H; Wiese M; Heinemann FM; Horn PA; Spengler U; Neumann-Haefelin C; Nattermann J; Timm J;
J Hepatol; 2013 Jan; 58(1):24-30. PubMed ID: 22925811
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
15. Expansion of Unique Hepatitis C Virus-Specific Public CD8
Mazouz S; Boisvert M; Abdel-Hakeem MS; Khedr O; Bruneau J; Shoukry NH
J Immunol; 2021 Aug; 207(4):1180-1193. PubMed ID: 34341170
[TBL] [Abstract][Full Text] [Related]
16. In vivo selection of a TCR Vbeta repertoire directed against an immunodominant influenza virus CTL epitope.
Zhong W; Reinherz EL
Int Immunol; 2004 Nov; 16(11):1549-59. PubMed ID: 15351787
[TBL] [Abstract][Full Text] [Related]
17. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
[TBL] [Abstract][Full Text] [Related]
18. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
[TBL] [Abstract][Full Text] [Related]
19. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
[TBL] [Abstract][Full Text] [Related]
20. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
